Meglumine Indometacinate
Therapeutic Group
Anti-inflammatory And Anti-rheumatic ProductsIndication Dosage
Pain And Moderate To Severe Inflammation In Rheumatic Disease, Osteoarthritis, And Other Musculoskeletal Disorders, Serious Musculoskeletal Injuries:
By Deep IM Inj Or IV Inj Or Iv Drip Infusion:
- Adults: Starting Dose 1 Amp, Every 12 Hr, Later On, 1 Amp, Either Daily Or Every Other Day In Chronic Cases
Acute Gout:
By Deep IM Inj Or IV Inj Or Iv Drip Infusion:
- Adults: Starting Dose 1 Amp, Every 12 Hr, Later On, 1 Amp, Either Daily Or Every Other Day In Chronic Cases
Content
- Inj: Per ml: Meglumine Indometacinate 200 Mcg; And Solvent
Pregnancy
Contraindicated In Pregnancy.
Stability
- Nsaid: Indole
Contra Indications
- Active Gi Bleeding And Ulceration, History Of Gibleeding Or Perforation Related To Previous Nsaid Therapy, History Of Recurrent Gi Haemorrhage Or Ulceration (two Or More Distinct Episodes), Severe Heart Failure, History Of Git Lesions, Aspirin Or Anti-inflammatory Drug-induced Allergy.
Precautions
- Active Gi Bleeding And Ulceration, History Of Gibleeding Or Perforation Related To Previous Nsaid Therapy, History Of Recurrent Gi Haemorrhage Or Ulceration (two Or More Distinct Episodes), Severe Heart Failure, History Of Git Lesions, Aspirin Or Anti-inflammatory Drug-induced Allergy.
Lactation
- Contraindicated
Side Effects
- Angioedema
- Blood Disorders
- Bronchospasm
- Colitis
- Crohn's Disease
- Depression
- Diarrhoea
- Dizziness
- Drowsiness
- Fluid Retention
- Gi Bleeding And Ulceration
- Gi Disturbances
- Haematuria
- Headache
- Hearing Disturbances
- Hypersensitivity Reactions
- Insomnia
- Nausea
- Nervousness
- Photosensitivity
- Raised Blood Pressure
- Rashes
- Renal Failure (especially In Patients With Preexisting Renal Impairment)
- tinnitus
- Vertigo.
- Rare: Hepatic Damage
- Interstitial Fibrosis Associated With Nsaids
- Stevens-johnson Syndrome
- Toxic Epidermal Necrolysis
- Visual Disturbances
- Exacerbation Of Symptoms In Asthma
- Thrombocytopenia
- Aseptic Meningitis